Top compounds associated with response to RPLP0


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0057 0.9
mRNA MK-2206 CTRPv2 pan-cancer AAC -0.0058 0.9
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.006 0.9
mRNA BRD-K34485477 CTRPv2 pan-cancer AAC 0.012 0.9
mRNA BRD-A02303741 CTRPv2 pan-cancer AAC -0.0058 0.9
mRNA Compound 1541A CTRPv2 pan-cancer AAC 0.0057 0.9
mRNA BRD-K58730230 CTRPv2 pan-cancer AAC 0.011 0.9
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.0053 0.9
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0053 0.9
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC 0.005 0.9
Download CSV